July 21, 2019Bulletins

Robust growth for e-CRO

Parexel Performance

February 15, 2006

Parexel International announced second-quarter results for the period ending December 31, 2005. Consolidated service revenue increased 10.3% to $149.8 million, compared with $135.8 million in the prior period. Operating income was $10.6 million, versus $7.5 million in the comparable quarter of the prior year. The breakdown by business segment: $108.9 million…more...

Page 67 of 67 pages « First  <  65 66 67

Plus: A Diary NDA

Adaptive Tools from Aptiv

With news about ER Squared, the NIH, China, Oklahoma, Insys, invivodata, and Aptiv

Friday News

Biotech Funding Trends

With news about Theorem Clinical Research, Parexel, FDA, BMS, AstraZeneca, BBK, TrialReach and Ernst & Young

Hedge Fund Deal

PPD Sold for $3.9 Billion

With news about CRF, FDA biosimilars, Merge, Dell, Pointcross, Bio-Optronics, Quintiles and PPD

Tuesday News


With news about SMS, ePharmaSolutions, Quintiles, public knowledge of FDA, BioClinica, OmniComm, PharmaPros and PPD

With Devices News

PPD In Play

News about FDA, medical devices, Pfizer, Quintiles, the Carylyle group and PPD

Monday News

FDA: App Regs for Devices

With news about China, CROs, obesity, BioClinica, biotechnology and device-related app regulations

© 2019 ClinPage. All Rights Reserved.